Zimmer Biomet
(NYSE: ZBH)
announced today that it reached a definitive agreement to acquire Ossis, a maker of personalized 3D-printed implants.
Ossis also offers complex hip replacements, including second-time replacements and ones involving bone tumors and trauma.
The company boasts rapid design and production of personalized implants. This aligns with ZB’s commitment to providing personalized experiences, according to a news release.
“Combining Ossis’s more than 16 years of clinical experience and engineering expertise with Zimmer Biomet’s extensive network across Asia Pacific, Europe, the Middle East and Africa demonstrates our commitment to bring transformative med tech advancements to patients in need,” said Sang Yi, Zimmer Biomet Asia Pacific group president.
ZB entered into an agreement with Ossis in July 2021. The agreement made Ossis the company’s Asia Pacific partner for patient-specific 3D-printed titanium hip joint replacements and other pelvic bone replacement surgery. They expanded their partnership to Europe, the Middle East and Africa in December 2022.
According to ZB, the acquisition “marks the continuation of a successful partnership.” The company expects it to allow for the continued enhancement of its hip reconstruction product portfolio.
“Zimmer Biomet shares our ethos of innovative technology with a strong patient focus,” said Kelvin Hyland, Ossis managing director. “Ossis is thrilled to join Zimmer Biomet’s established portfolio with cutting-edge solutions and expert capabilities.”
